Skip to main content
MRK logo
MRK
(NYSE)
Merck & Co., Inc.
$120.87-- (--)
Loading... - Market loading

Merck & Co. (MRK) Stock Price & Financial Analysis

Merck & Co. Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$119.22 - $121.65
52-Week High$125.14
52-Week Low$73.31
Open$120.37
Volume6.25M
Average Volume (3M)6.25M
Market Cap300.72B
Shares Outstanding2.49B
P/E Ratio (TTM)16.47
Forward P/E15.44
Price to Sales (P/S)4.62
Price to Book (P/B)5.72
EV/EBITDA12.80
Revenue (TTM)65.01B
Net Income (TTM)18.25B
Free Cash Flow (TTM)12.36B
EPS (TTM)$7.34
Profit Margin28.08%
Operating Margin41.19%
Return on Equity (ROE)34.70%
Debt to Equity0.96
50-Day MA$117.05
200-Day MA$96.19
52-Week Change38.71%
Annual Dividend$3.32
Dividend Yield2.75%
Payout Ratio45.25%
Last Dividend Ex-DateMar 16, 2026

Frequently Asked Questions About Merck & Co.

What is the current stock price for MRK?

As of the latest trading session, MRK stock trades at $120.87. The 52-week range is $73.31–$125.14, with a day range of $119.22–$121.65.

What is the P/E ratio for MRK?

Merck & Co.'s trailing P/E ratio is 16.5, meaning investors pay $16.5 for every $1 of annual earnings. The forward P/E is 15.4, reflecting analyst expectations for future earnings. Merck & Co. operates in the Healthcare sector.

Does MRK pay dividends?

Yes, Merck & Co. pays a 2.75% annual dividend yield ($3.32 per share). The payout ratio is 45.3%. The last ex-dividend date was 2026-03-16.

What do analysts recommend for MRK?

Based on 10 analysts, the consensus for MRK is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MRK?

Merck & Co.'s market capitalization is $300.72B, classifying it as a mega-cap company. Merck & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.